Region: Europe

Featured in Special Report 2024 Q2: Money, money, money

28 June 2024

Featured in Special Report 2024 Q2: Money, money, money

28 June 2024

Featured in Special Report 2024 Q2: Money, money, money

28 June 2024

SEP disputes and other complex infringement spats are taking longer than expected at Europe’s new court

27 June 2024

Alexion Pharmaceuticals denied PI requests against biosimilar eculizumab producers Amgen and Samsung Bioepis

27 June 2024

The 2024 IP Hall of Fame inductee speaks to IAM about everything from Finnish philosophy to new areas of SEP licensing as well as the threat posed by the EU’s proposed SEP licensing regulation

25 June 2024

AI, counterfeits and legislative overhauls are changing the game but contributors to the IAM Guide to Life Sciences offer strategic steps to help companies stay one step ahead

24 June 2024

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

24 June 2024

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Europe is one of the most important markets for the life sciences and pharma industry, and Germany is one of its key jurisdictions. Patenting life science inventions in Germany can be challenging as some biological subject matter is excluded from patent protection, so careful patent drafting is crucial in order to obtain allowable claims.

24 June 2024

Chinese company is one of very few smartphone/computer companies asserting its patents at the Unified Patent Court

24 June 2024